基因名 | 疾病 | 靶向药 | 化疗药 | 基因突变 | 临床解释 |
---|---|---|---|---|---|
GNA13 | 0 | 0 | |||
GRIN2A | 0 | 0 | |||
GABRA6 | 0 | 0 | |||
GSK3B | 0 | 0 | |||
GRM3 | 0 | 0 | |||
GID4 | 0 | 0 | |||
GATA4 | 0 | 0 | |||
GLI2 | 0 | 0 | |||
GATA6 | 0 | 0 | |||
GATA3 | 0 | 0 | |||
GATA1 | 0 | 0 | |||
GALNT12 | 0 | 0 | |||
GREM1 | 0 | 0 | |||
GALNT14 | 0 | 0 | |||
GEN1 | 0 | 0 | |||
GGH | 0 | 0 | |||
GLI3 | 0 | 0 | |||
GPC3 | 0 | 0 | |||
GPS2 | 0 | 0 | |||
GSTM1 | 0 | 0 | |||
GSTT1 | 0 | 0 | |||
GPR124 | 0 | 0 | |||
G3BP1 | 0 | 0 | |||
G3BP2 | 0 | 0 | |||
G6PC3 | 0 | 0 | |||
G6PC | 0 | 0 | |||
GAB2 | 0 | 0 | |||
GABRA2 | 0 | 0 | |||
GABRP | 0 | 0 | |||
GALNT11 | 0 | 0 | |||
GANC | 0 | 0 | |||
GAPDH | 0 | 0 | |||
GAST | 0 | 0 | |||
GDF1 | 0 | 0 | |||
GDF15 | 0 | 0 | |||
GFRAL | 0 | 0 | |||
GIGYF1 | 0 | 0 | |||
GJB2 | 0 | 0 | |||
GKN2 | 0 | 0 | |||
GLB1L3 | 0 | 0 | |||
GMEB1 | 0 | 0 | |||
GMPS | 0 | 0 | |||
GNA12 | 0 | 0 | |||
GNG2 | 0 | 0 | |||
GNRHR | 0 | 0 | |||
GOPC | 0 | 0 | |||
GPAT3 | 0 | 0 | |||
GPM6A | 0 | 0 | |||
GPR101 | 0 | 0 | |||
GPR158 | 0 | 0 | |||
GPX1 | 0 | 0 | |||
GRB2 | 0 | 0 | |||
GRB7 | 0 | 0 | |||
GRID1 | 0 | 0 | |||
GRIK3 | 0 | 0 | |||
GRM8 | 0 | 0 | |||
GSTA1 | 0 | 0 | |||
GSTM3 | 0 | 0 | |||
GSTM4 | 0 | 0 | |||
GSTM5 | 0 | 0 | |||
GUSB | 0 | 0 | |||
GADD45A | 卵巢癌 | 1 | 1 | ||
GATA2 | 肺腺癌 | 硼替佐米, | 法舒地尔, | 1 | 1 |
GAS6 | 口腔鳞状细胞癌 | 多西他赛, | 1 | 2 | |
GLI1 | 细胞周瘤 | 1 | 1 | ||
GNA11 | 葡萄膜黑色素瘤 | AEB071,卡博替尼,JQ1,PD0325901,司美替尼,曲美替尼, | 2 | 5 | |
GSTP1 | 结直肠癌,卵巢癌 | FolfoxProtocol, | 卡铂,顺铂,紫杉醇, | 2 | 2 |
GNAQ | 皮肤黑色素瘤,葡萄膜黑色素瘤 | AEB071,Refametinib,卡博替尼,JQ1,PD0325901,PLX4720,司美替尼,曲美替尼,维莫非尼, | 3 | 8 | |
GNAS | 膀胱尿路上皮癌,乳腺癌,慢性淋巴细胞白血病,透明细胞肾细胞癌,结直肠癌,食管癌,滤泡性甲状腺癌,肝内胆管癌,非小细胞肺癌,黑色素瘤,腹膜假黏液瘤 | 西妥昔单抗,厄洛替尼,吉非替尼,Radioactive Iodine,维莫非尼, | 氟尿嘧啶,顺铂,伊立替康, | 4 | 12 |